Logo image of CPT

CAMDEN PROPERTY TRUST (CPT) Stock Fundamental Analysis

USA - NYSE:CPT - US1331311027 - REIT

102.4 USD
+0.55 (+0.54%)
Last: 10/17/2025, 8:04:09 PM
102.4 USD
0 (0%)
After Hours: 10/17/2025, 8:04:09 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CPT. CPT was compared to 20 industry peers in the Residential REITs industry. While CPT is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, CPT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CPT had positive earnings in the past year.
CPT had a positive operating cash flow in the past year.
Each year in the past 5 years CPT has been profitable.
In the past 5 years CPT always reported a positive cash flow from operatings.
CPT Yearly Net Income VS EBIT VS OCF VS FCFCPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.71%, CPT is in line with its industry, outperforming 60.00% of the companies in the same industry.
With a Return On Equity value of 3.39%, CPT perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
With a Return On Invested Capital value of 2.66%, CPT perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
CPT had an Average Return On Invested Capital over the past 3 years of 2.74%. This is in line with the industry average of 2.59%.
Industry RankSector Rank
ROA 1.71%
ROE 3.39%
ROIC 2.66%
ROA(3y)4.38%
ROA(5y)3.73%
ROE(3y)8.22%
ROE(5y)7.1%
ROIC(3y)2.74%
ROIC(5y)2.62%
CPT Yearly ROA, ROE, ROICCPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

With a Profit Margin value of 9.97%, CPT perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
CPT's Profit Margin has declined in the last couple of years.
CPT has a Operating Margin (18.78%) which is comparable to the rest of the industry.
CPT's Operating Margin has declined in the last couple of years.
CPT has a Gross Margin of 61.19%. This is in the better half of the industry: CPT outperforms 75.00% of its industry peers.
In the last couple of years the Gross Margin of CPT has remained more or less at the same level.
Industry RankSector Rank
OM 18.78%
PM (TTM) 9.97%
GM 61.19%
OM growth 3Y-0.89%
OM growth 5Y-4.58%
PM growth 3Y-26.44%
PM growth 5Y-13.1%
GM growth 3Y0.19%
GM growth 5Y-0.06%
CPT Yearly Profit, Operating, Gross MarginsCPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

CPT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CPT has less shares outstanding
Compared to 5 years ago, CPT has more shares outstanding
CPT has a better debt/assets ratio than last year.
CPT Yearly Shares OutstandingCPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CPT Yearly Total Debt VS Total AssetsCPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CPT has an Altman-Z score of 1.52. This is a bad value and indicates that CPT is not financially healthy and even has some risk of bankruptcy.
CPT's Altman-Z score of 1.52 is fine compared to the rest of the industry. CPT outperforms 75.00% of its industry peers.
CPT has a debt to FCF ratio of 9.23. This is a negative value and a sign of low solvency as CPT would need 9.23 years to pay back of all of its debts.
CPT has a Debt to FCF ratio of 9.23. This is amongst the best in the industry. CPT outperforms 95.00% of its industry peers.
A Debt/Equity ratio of 0.83 indicates that CPT is somewhat dependend on debt financing.
The Debt to Equity ratio of CPT (0.83) is better than 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 9.23
Altman-Z 1.52
ROIC/WACC0.37
WACC7.22%
CPT Yearly LT Debt VS Equity VS FCFCPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 0.10 indicates that CPT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.10, CPT is doing worse than 80.00% of the companies in the same industry.
A Quick Ratio of 0.10 indicates that CPT may have some problems paying its short term obligations.
CPT's Quick ratio of 0.10 is on the low side compared to the rest of the industry. CPT is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.1
CPT Yearly Current Assets VS Current LiabilitesCPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for CPT have decreased strongly by -62.09% in the last year.
The Earnings Per Share has been growing slightly by 0.43% on average over the past years.
CPT shows a small growth in Revenue. In the last year, the Revenue has grown by 0.77%.
CPT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.46% yearly.
EPS 1Y (TTM)-62.09%
EPS 3Y13.97%
EPS 5Y0.43%
EPS Q2Q%-22.5%
Revenue 1Y (TTM)0.77%
Revenue growth 3Y10.52%
Revenue growth 5Y8.46%
Sales Q2Q%2.42%

3.2 Future

The Earnings Per Share is expected to grow by 1.21% on average over the next years.
The Revenue is expected to grow by 4.51% on average over the next years.
EPS Next Y-18.57%
EPS Next 2Y-11.25%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue Next Year2.44%
Revenue Next 2Y2.53%
Revenue Next 3Y3.29%
Revenue Next 5Y4.51%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CPT Yearly Revenue VS EstimatesCPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
CPT Yearly EPS VS EstimatesCPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 74.20, CPT can be considered very expensive at the moment.
CPT's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of CPT to the average of the S&P500 Index (27.40), we can say CPT is valued expensively.
The Price/Forward Earnings ratio is 69.15, which means the current valuation is very expensive for CPT.
CPT's Price/Forward Earnings ratio is in line with the industry average.
CPT is valuated expensively when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 74.2
Fwd PE 69.15
CPT Price Earnings VS Forward Price EarningsCPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPT indicates a somewhat cheap valuation: CPT is cheaper than 80.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CPT indicates a rather cheap valuation: CPT is cheaper than 85.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 26.41
EV/EBITDA 16.63
CPT Per share dataCPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)172.14
EPS Next 2Y-11.25%
EPS Next 3Y1.21%

5

5. Dividend

5.1 Amount

CPT has a Yearly Dividend Yield of 4.12%, which is a nice return.
Compared to an average industry Dividend Yield of 7.18, CPT is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.36, CPT pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.12%

5.2 History

The dividend of CPT has a limited annual growth rate of 4.99%.
CPT has been paying a dividend for at least 10 years, so it has a reliable track record.
CPT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.99%
Div Incr Years7
Div Non Decr Years14
CPT Yearly Dividends per shareCPT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

293.28% of the earnings are spent on dividend by CPT. This is not a sustainable payout ratio.
The dividend of CPT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP293.28%
EPS Next 2Y-11.25%
EPS Next 3Y1.21%
CPT Yearly Income VS Free CF VS DividendCPT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CPT Dividend Payout.CPT Dividend Payout, showing the Payout Ratio.CPT Dividend Payout.PayoutRetained Earnings

CAMDEN PROPERTY TRUST

NYSE:CPT (10/17/2025, 8:04:09 PM)

After market: 102.4 0 (0%)

102.4

+0.55 (+0.54%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners96.78%
Inst Owner Change-0.03%
Ins Owners1.25%
Ins Owner Change-0.27%
Market Cap10.94B
Analysts73.1
Price Target124.38 (21.46%)
Short Float %2.76%
Short Ratio3.19
Dividend
Industry RankSector Rank
Dividend Yield 4.12%
Yearly Dividend4.15
Dividend Growth(5Y)4.99%
DP293.28%
Div Incr Years7
Div Non Decr Years14
Ex-Date09-30 2025-09-30 (1.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.57%
Min EPS beat(2)-0.59%
Max EPS beat(2)5.72%
EPS beat(4)1
Avg EPS beat(4)-4.05%
Min EPS beat(4)-12.31%
Max EPS beat(4)5.72%
EPS beat(8)4
Avg EPS beat(8)60.9%
EPS beat(12)7
Avg EPS beat(12)54.23%
EPS beat(16)8
Avg EPS beat(16)82.47%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.57%
Max Revenue beat(2)-0.45%
Revenue beat(4)0
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)-0.45%
Revenue beat(8)0
Avg Revenue beat(8)-0.95%
Revenue beat(12)0
Avg Revenue beat(12)-0.89%
Revenue beat(16)3
Avg Revenue beat(16)5.31%
PT rev (1m)-1.08%
PT rev (3m)-5.15%
EPS NQ rev (1m)4.83%
EPS NQ rev (3m)5.22%
EPS NY rev (1m)21.5%
EPS NY rev (3m)17.73%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)0.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.31%
Valuation
Industry RankSector Rank
PE 74.2
Fwd PE 69.15
P/S 7.01
P/FCF 26.41
P/OCF 13.8
P/B 2.39
P/tB 2.39
EV/EBITDA 16.63
EPS(TTM)1.38
EY1.35%
EPS(NY)1.48
Fwd EY1.45%
FCF(TTM)3.88
FCFY3.79%
OCF(TTM)7.42
OCFY7.25%
SpS14.61
BVpS42.93
TBVpS42.93
PEG (NY)N/A
PEG (5Y)172.14
Profitability
Industry RankSector Rank
ROA 1.71%
ROE 3.39%
ROCE 3.37%
ROIC 2.66%
ROICexc 2.67%
ROICexgc 2.75%
OM 18.78%
PM (TTM) 9.97%
GM 61.19%
FCFM 26.55%
ROA(3y)4.38%
ROA(5y)3.73%
ROE(3y)8.22%
ROE(5y)7.1%
ROIC(3y)2.74%
ROIC(5y)2.62%
ROICexc(3y)2.77%
ROICexc(5y)2.72%
ROICexgc(3y)2.85%
ROICexgc(5y)2.8%
ROCE(3y)3.46%
ROCE(5y)3.32%
ROICexcg growth 3Y0.86%
ROICexcg growth 5Y-2.21%
ROICexc growth 3Y1.1%
ROICexc growth 5Y-2.02%
OM growth 3Y-0.89%
OM growth 5Y-4.58%
PM growth 3Y-26.44%
PM growth 5Y-13.1%
GM growth 3Y0.19%
GM growth 5Y-0.06%
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 9.23
Debt/EBITDA 4.32
Cap/Depr 63.86%
Cap/Sales 24.25%
Interest Coverage 2.12
Cash Conversion 89.5%
Profit Quality 266.19%
Current Ratio 0.1
Quick Ratio 0.1
Altman-Z 1.52
F-Score4
WACC7.22%
ROIC/WACC0.37
Cap/Depr(3y)72.34%
Cap/Depr(5y)87.06%
Cap/Sales(3y)27.91%
Cap/Sales(5y)32.43%
Profit Quality(3y)124.82%
Profit Quality(5y)99.59%
High Growth Momentum
Growth
EPS 1Y (TTM)-62.09%
EPS 3Y13.97%
EPS 5Y0.43%
EPS Q2Q%-22.5%
EPS Next Y-18.57%
EPS Next 2Y-11.25%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue 1Y (TTM)0.77%
Revenue growth 3Y10.52%
Revenue growth 5Y8.46%
Sales Q2Q%2.42%
Revenue Next Year2.44%
Revenue Next 2Y2.53%
Revenue Next 3Y3.29%
Revenue Next 5Y4.51%
EBIT growth 1Y-7.46%
EBIT growth 3Y9.54%
EBIT growth 5Y3.5%
EBIT Next Year207.48%
EBIT Next 3Y49.06%
EBIT Next 5Y37.61%
FCF growth 1Y7.34%
FCF growth 3Y36.84%
FCF growth 5Y20.83%
OCF growth 1Y1.55%
OCF growth 3Y10.3%
OCF growth 5Y6.88%